Failed dental chain lists no assets, $3.6 million debt
A New York dental chain that closed offices in 13 states, including eight in Indiana, without warning late last year lists no assets and liabilities of $3.6 million in a bankruptcy filing.
Health Care & Life Sciences
Articles
States suing over health care law collect funding
Federal officials announced Tuesday they are awarding more money to help states carry out President Barack Obama's health care overhaul. Seven states that are suing to overturn the landmark law are also on the list for funding.
IU Health reports most serious medical errors
Indiana’s largest and busiest medical system committed 19 preventable errors last year at its hospitals in Indianapolis and other cities, three fewer than in 2009, according to a report released Monday.
Bed sores most common 2010 Indiana medical errors
The state report cited 34 stage three or stage four bed sores after hospital admissions. It also found 33 foreign objects left behind after surgeries.
Drugmakers, pharmacists at odds
Indianapolis-based Eli Lilly and Co. recently rejected CVS Caremark’s demands for big price discounts on its insulins, leading CVS to kick Lilly’s insulins off its list of recommended drugs.
Brokers get hope on commissions
The National Association of Insurance Commissioners passed a resolution Nov. 22 that urges Congress and the Obama administration to exclude benefits brokers’ commissions from the new requirement that insurers spend only 15 percent to 20 percent of the premiums they collect on administration and profits.
SEC accuses Positron CEO of misleading investors
Regulators allege CEO Patrick G. Rooney diverted millions of dollars from a hedge fund into the struggling Fishers company without investors’ knowledge.
Community to move rehab service to new $23M hospital
Community Health Network plans to move its inpatient rehabilitation facility from its east-side hospital to a new $23 million, 60-bed facility in the Castleton neighborhood.
Health insurers push comparison shopping
Indianapolis-based Anthem Blue Cross and Blue Shield and Minnesota-based UnitedHealthcare say they’re responding to demands from employers, who are desperate to rein in spiraling health benefits costs and have begun embracing the idea that to do so they must change their workers’ approach to health and health care.
BROWN: The real reason hospitals are buying doctor offices
Raising prices is easier when numbers are limited.
ZWIRN: Most health care reform will happen at local level
Smart coalitions will cut costs, improve quality.
SMITH: Small steps, big results: gauging design’s impact
Metrics make a difference in health care facilities.
JONES: Patent reform is mixed bag for life sciences companies
For Indiana’s life sciences sector, the change both raises hopes and creates challenges for continued growth.
IU Health is national player in multi-organ transplants
Unusual surgeries bring certain amount of prestige, but not a lot of profit.
Decatur Vein Clinic branches out
In little more than a decade, former Conseco director Dr. David Decatur has turned his single-office family practice into a multistate chain of vein clinics. A 14th location is planned.
Slabosky retiring from IU Health Plans
Alex Slabosky, who ran the M-Plan HMO for 20 years, is retiring from IU Health and has been replaced by the hospital’s treasurer, Ryan Kitchell.
UnitedHealth to acquire Medicare insurer XLHealth
UnitedHealth Group Inc. said it will acquire XLHealth Corp., a provider of managed care for chronically ill Medicare members. Indianapolis-based WellPoint Inc. had been considering a possible acquisition of the company.
Few employers say they’ll drop health coverage
Few employers in Indiana say they’re likely to drop health benefits after state insurance exchanges are formed in 2014, according to a new survey by the health benefits firm Mercer.
Lilly committed to China despite IP woes
Indianapolis-based Eli Lilly and Co. is one of several Western pharmaceutical firms that see China as a linchpin of growth in coming years, due to patent expirations and a slowdown in government reimbursements for prescription medicines in the U.S. and European markets.
Potential Lilly drug doubles good cholesterol
Eli Lilly and Co.’s experimental drug doubled levels of good cholesterol in a study, setting up a race with Merck & Co. and Roche Holding AG to develop a new class of medicines to lower heart risk.